Current Research Information SysTem In Norway
 
 

 Norsk versjon


 
Mainpage
Research results/NVI
Researchers
Projects
Research units
Log in
About Cristin
 
 
   
Back to search     Short format     Full format    
Export to


Showing results 1-27 of 27

2018
1 Navarro-Fernandez, Jose; de la Morena-Barrio, Maria Eugenia; Martinez-Alonso, Emma; Dybedal, Ingunn; Toderici, Mara; Bohdan, Nataliya; Minano, Antonia; Heimdal, Ketil Riddervold; Abildgaard, Ulrich; Martinez-Menarguez, Jose Angel; Corral, Javier; Vicente, Vicente.
Biochemical and cellular consequences of the antithrombin p.Met1? mutation identified in a severe thrombophilic family. OncoTarget 2018 ;Volume 9.(69) p. 33202-33214
OUS Untitled
 
2013
2 Abildgaard, Ulrich; Heimdal, Ketil Riddervold.
Pathogenesis of the syndrome of hemolysis, elevated liver enzymes, and low platelet count (HELLP): a review. European Journal of Obstetrics, Gynecology, and Reproductive Biology 2013 ;Volume 166.(2) p. 117-123
OUS Untitled
 
2012
3 Toth, Orsolya; Conard, Jacqueline; Losonczy, Hajna; Reger, Barbara; Andresen, Marianne Seierstad; Horellou, Marie-Helene; Mozes, Reka; Abildgaard, Ulrich.
High sensitivity of the global CIP assay for hereditary thrombophilia. Thrombosis Research 2012 ;Volume 130. p. S133-S133
OUS UiO Untitled
 
2011
4 Andresen, Marianne Seierstad; Sandven, Irene; Brunborg, Cathrine; Johansen, Anne Mette; Strekerud, Finn; Abdelnoor, Michael; Smith, Pål; Abildgaard, Ulrich.
Mortality and recurrence after treatment of VTE: Long term follow-up of patients with good life-expectancy. Thrombosis Research 2011 ;Volume 127.(6) p. 540-546
AHUS OUS Untitled
 
2009
5 Abildgaard, Ulrich; Sandset, Per Morten; Hammerstrøm, Jens; Gjestvang, Finn Tore; Tveit, Arnljot.
Management of pregnant women with mechanical heart valve prosthesis: Thromboprophylaxis with Low molecular weight heparin. Thrombosis Research 2009 ;Volume 124.(3) p. 262-267
NTNU OUS SSHF STO UiO VV Untitled
 
2007
6 Andresen, Marianne Seierstad; Eilertsen, Anette Løken; Abildgaard, Ulrich; Sandset, Per Morten.
Hormone therapy and raloxifene reduce the coagulation inhibitor potential. Blood Coagulation and Fibrinolysis 2007 ;Volume 18. p. 455-460
OUS UiO Untitled
 
7 Brosstad, Frank; Abildgaard, Ulrich; Breivik, Harald; Sellevold, Olav F Münter.
Marevan og blodplatehemmere ved kirurgi. Tidsskrift for Den norske legeforening 2007 Suppl. vedlegg p. -
NTNU Untitled
 
2006
8 Jacobsen, EM; Trettenes, EJ; Wisløff, Finn Georg B; Abildgaard, Ulrich.
Detection and quantification of lupus anticoagulants in plasma from heparin treated patients, using addition of polybrene. Thrombosis Journal 2006 ;Volume 4. p. 3-8
UiO Untitled
 
2004
9 Andresen, Marianne S; Abildgaard, Ulrich; Liestøl, Sigurd; Sandset, Per Morten; Mowinckel, M.C.; Ødegaard, Ole Rasmus; Larsen, ML.; Diep, Lien.
The ability of three global plasma assays to recognize thrombophilia. Thrombosis Research 2004 ;Volume 113.(6) p. 411-7
UiO Untitled
 
10 Sandset, Per Morten; Abildgaard, Ulrich.
Tissue factor pathway inhibitor revisited. Journal of Thrombosis and Haemostasis 2004 ;Volume 2.(12) p. 2242-2243
UiO Untitled
 
2002
11 Iversen, Nina; Lindahl, Anne Karin; Abildgaard, Ulrich.
Elevated plasma Levels of the factor Xa-TFPI complex in cancer patients. Thrombosis Research 2002 ;Volume 105.(1) p. 33-36
OUS UiO Untitled
 
1994
12 Boffa, Marie-Claire; Lapeyrere, C; Berard, M; Lindahl, Anne Karin; Flageul, B; Chemaly, P; Abildgaard, Ulrich; Dubertret, L.
Plasma thrombomodulin Level in malignancy varies according to the tumor type. La Nouvelle revue francaise 1994
OUS UiO Untitled
 
1993
13 Abildgaard, Ulrich; Sandset, Per Morten; Lindahl, Anne Karin.
Tissue Factor Pathway Inhibitor. I: Recent Advances in Blood Coagulation 6. : Churchill Livingstone 1993 ISBN 978-0443047558.
OUS UiO Untitled
 
14 Lindahl, Anne Karin; Boffa, Marie-Claire; Abildgaard, Ulrich.
Increased plasma thrombomodulin in cancer patients. Thrombosis and Haemostasis 1993
OUS UiO Untitled
 
15 Lindahl, Anne Karin; Boffa, Marie-Claire; Abildgaard, Ulrich.
Tissue factor pathway inhibitor. Thrombosis and Haemostasis 1993
OUS UiO Untitled
 
1992
16 Kristensen, HI; Østergaard, PB; Nordfang, O; Abildgaard, Ulrich; Lindahl, Anne Karin.
Effect of tissue factor pathway inhibitor (TFPI) in the HEPTEST assay and in an amidolytic anti factor Xa assay for LMW heparin. Thrombosis and Haemostasis 1992
OUS UiO Untitled
 
17 Lindahl, Anne Karin; Sandset, Per Morten; Abildgaard, Ulrich.
The present status of tissue factor pathway inhibitor. Blood Coagulation and Fibrinolysis 1992
OUS UiO Untitled
 
1991
18 Abildgaard, Ulrich; Lindahl, Anne Karin; Sandset, Per Morten.
Heparin requires both antithrombin and extrinsic pathway inhibitor for its anticoagulant effect in human blood. Thrombosis and Haemostasis 1991
OUS UiO Untitled
 
19 Lindahl, Anne Karin; Abildgaard, Ulrich; Larsen, ML; Aamodt, LM; Nordfang, O; Beck, TC.
Extrinsic pathway inhibitor (EPI) and the post-heparin anticoagulant effect in tissue thromboplastin induced coagulation. Thrombosis Research 1991
OUS UiO Untitled
 
20 Lindahl, Anne Karin; Abildgaard, Ulrich; Larsen, ML; Staalesen, R; Hammer, AK; Sandset, PM; Nordfang, O; Beck, TC.
Extrinsic pathway inhibitor (EPI) released to the blood by heparin is a more powerful coagulation inhibitor than is recombinant EPI. Thrombosis Research 1991
OUS UiO Untitled
 
21 Lindahl, Anne Karin; Abildgaard, Ulrich; Staalesen, R.
The anticoagulant effect in heparinized blood and plasma resulting from interactions with extrinsic pathway inhibitor. Thrombosis Research 1991
OUS Untitled
 
22 Lindahl, Anne Karin; Jacobsen, PB; Sandset, Per Morten; Abildgaard, Ulrich.
Tissue factor pathway inhibitor with high anticoagulant activity is increased in post-heparin plasma and in plasma from cancer patients. Blood Coagulation and Fibrinolysis 1991
OUS Untitled
 
23 Norrheim, L; Abildgaard, Ulrich; Larsen, ML; Lindahl, Anne Karin.
Involvement of the extrinsic pathway in the activities of low molecular weight heparins. Thrombosis Research 1991
OUS Untitled
 
24 Sandset, Per Morten; Larsen, ML; Abildgaard, Ulrich; Lindahl, Anne Karin; Ødegaard, OR.
Chromogenic substrate assay of extrinsic pathway inhibitor (EPI): Levels in the normal population and relation to cholesterol. Blood Coagulation and Fibrinolysis 1991
OUS UiO Untitled
 
1990
25 Lindahl, Anne Karin; Abildgaard, Ulrich; Stokke, G.
Release of extrinsic pathway inhibitor after heparin injection: increased response in cancer patients. Thrombosis Research 1990
OUS Untitled
 
26 Lindahl, Anne Karin; Sandset, Per Morten; Abildgaard, Ulrich.
Indices of hypercoagulation in cancer as compared with those in acute inflammation and acute infarction. Thrombosis and Haemostasis 1990
OUS Untitled
 
1989
27 Lindahl, Anne Karin; Sandset, Per Morten; Abildgaard, Ulrich; Andersson, TR; Harbitz, Thorstein Backe.
High plasma levels of extrinsic pathway inhibitor and low levels of other coagulation inhibitors in advanced cancer. Acta Chiropterologica 1989
OUS Untitled